These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21218351)

  • 21. [Transmissible spongiform encephalopathies (TSE): old diseases with new explosive force].
    Borchers K
    Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):81-90. PubMed ID: 11938571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of prion protein in transmission of prions and in pathogenesis of spongiform encephalopathies].
    Raeber AJ; Klein MA; Frigg R; Brandner S; Blättler T; Aguzzi A
    Wien Med Wochenschr; 1998; 148(4):74-7. PubMed ID: 9611346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prions and prion diseases: fundamentals and mechanistic details.
    Ryou C
    J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The risk of variant Creutzfeldt-Jakob disease in the Netherlands and the effect of preventive measures].
    Kersseboom R; Koekoek SC; Richardus JH
    Ned Tijdschr Geneeskd; 2002 Apr; 146(16):754-9. PubMed ID: 11998352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prions and orthopedic surgery.
    Doerr HW; Cinatl J; Stürmer M; Rabenau HF
    Infection; 2003 Jun; 31(3):163-71. PubMed ID: 12789474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transmissible spongiform encephalopathies--illnesses in the human].
    Budka H
    Wien Med Wochenschr; 1998; 148(4):86-95. PubMed ID: 9611348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.
    Bruce ME; Will RG; Ironside JW; McConnell I; Drummond D; Suttie A; McCardle L; Chree A; Hope J; Birkett C; Cousens S; Fraser H; Bostock CJ
    Nature; 1997 Oct; 389(6650):498-501. PubMed ID: 9333239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of transmissible spongiform encephalopathy and methods for prion inactivation].
    Papacchini M; Mansi A; Marta I
    Med Lav; 2003; 94(3):271-84. PubMed ID: 12918319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The same prion strain causes vCJD and BSE.
    Hill AF; Desbruslais M; Joiner S; Sidle KC; Gowland I; Collinge J; Doey LJ; Lantos P
    Nature; 1997 Oct; 389(6650):448-50, 526. PubMed ID: 9333232
    [No Abstract]   [Full Text] [Related]  

  • 31. [Much news on the prion front].
    Norrby E
    Lakartidningen; 2010 May 5-11; 107(18):1218-24. PubMed ID: 20521593
    [No Abstract]   [Full Text] [Related]  

  • 32. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
    Hilton DA
    J Pathol; 2006 Jan; 208(2):134-41. PubMed ID: 16362983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1152-4. PubMed ID: 18946463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
    Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
    Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic prion diseases in humans: an update.
    Barrenetxea G
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):165-9. PubMed ID: 22951159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human prion diseases: epidemiology and integrated risk assessment.
    Glatzel M; Ott PM; Linder T; Gebbers JO; Gmür A; Wüst W; Huber G; Moch H; Podvinec M; Stamm B; Aguzzi A
    Lancet Neurol; 2003 Dec; 2(12):757-63. PubMed ID: 14636781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmissible spongiform encephalopathy update and implications for blood safety.
    Ricketts MN; Brown P
    Clin Lab Med; 2003 Mar; 23(1):129-37. PubMed ID: 12733428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prions and the human transmissible spongiform encephalopathies.
    Scully C; Smith AJ; Bagg J
    Dent Clin North Am; 2003 Jul; 47(3):493-516. PubMed ID: 12848461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.
    Lefrère JJ; Hewitt P
    Transfusion; 2009 Apr; 49(4):797-812. PubMed ID: 19170997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.